Use of peptides as therapeutic agent for autoimmune diseases and bone diseases
US11648286B2 · kind B2 · utility
0Cited by
1References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 14, 2018 |
| Grant date | May 16, 2023 |
| Priority date | — |
| Expiry date | Jun 15, 2039 |
Classification
- Technology area (CPC —)General
Abstract
The present invention relates to use of peptides as a therapeutic agent, wherein it has been confirmed that the peptides of the present invention significantly inhibit the activity of T cells and the differentiation of T helper 17 cells (Th17 cells), which are associated with autoimmune disease, reduce the secretion of inflammatory cytokine IL-6, and have remarkable effects of treating and improving arthritis in an animal model of arthritis. Therefore, the peptides may be used as an active ingredient in therapeutic agents for various autoimmune diseases such as bone disease, inflammatory disease or rheumatoid arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.